Superior vena cava syndrome with malignant causes

New England Journal of Medicine

Volumn 356, Issue 18, 2007, Pages 1862-1869

  Wilson, Lynn D ^a,b   Detterbeck, Frank C ^a,b   Yahalom, Joachim ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE CANCER CENTER   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTINEOPLASTIC AGENT; DEXAMETHASONE; DIURETIC AGENT;

ABDOMEN; ANAMNESIS; ANTICOAGULANT THERAPY; ARTICLE; BREATHING RATE; BYPASS SURGERY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CIGARETTE SMOKING; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DECREASED APPETITE; DYSPNEA; FATIGUE; HEART RATE; HUMAN; IMAGING SYSTEM; MALIGNANT NEOPLASTIC DISEASE; NECK SWELLING; PATHOGENESIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STENT; STRIDOR; SUPERIOR CAVA VEIN SYNDROME; SWELLING; THORAX; TREATMENT RESPONSE; VASCULAR DISEASE; VASCULAR DISTENTION; VIGNETTE; COMPUTER ASSISTED TOMOGRAPHY; EDEMA; HISTOLOGY; LUNG TUMOR; MALE; MEDIASTINUM TUMOR; MIDDLE AGED; PHYSIOLOGY; REVIEW; SUPERIOR CAVA VEIN; THORAX RADIOGRAPHY;

DYSPNEA; EDEMA; HUMANS; LUNG NEOPLASMS; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; RADIOGRAPHY, THORACIC; SUPERIOR VENA CAVA SYNDROME; TOMOGRAPHY, X-RAY COMPUTED; VENA CAVA, SUPERIOR;

EID: 34247887692     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcp067190     Document Type: Article

References (49)

1. Armstrong BA, Perez CA, Simpson JR, Hederman MA. Role of irradiation in the management of superior vena cava syndrome. Int J Radiat Oncol Biol Phys 1987;13:531-9.
2. Abner A. Approach to the patient who presents with superior vena cava obstruction. Chest 1993;103:Suppl 4:394S-397S.
3. Ostler PJ, Clarke DP, Watkinson AF, Gaze MN. Superior vena cava obstruction: a modern management strategy. Clin Oncol (R Coll Radiol) 1997;9:83-9.
4. Yellin A, Rosen A, Reichert N, Lieberman Y. Superior vena cava syndrome: the myth - the facts. Am Rev Respir Dis 1990;141:1114-8.
5. Schraufnagel DE, Hill R, Leech JA, Pare JA. Superior vena caval obstruction: is it a medical emergency? Am J Med 1981;70:1169-74.
6. Kim HJ, Kim HS, Chung SH. CT diagnosis of superior vena cava syndrome: importance of collateral vessels. AJR Am J Roentgenol 1993;161:539-42.
7. Trigaux JP, Van Beers B. Thoracic collateral venous channels: normal and pathologic CT findings. J Comput Assist Tomogr 1990;14:769-73.
8. Gonzales-Fajardo JA, Garcia-Yuste M, Florez S, Ramos G, Alvarez T, Coca JM. Hemodynamic and cerebral repercussions arising from surgical interruption of the superior vena cava: experimental model. J Thorac Cardiovasc Surg 1994;107:1044-9.
9. Mineo TC, Ambrogi V, Nofroni I, Pistolese C. Mediastinoscopy in superior vena cava obstruction: analysis of 80 consecutive patients. Ann Thorac Surg 1999;68:223-6.
10. Kishi K, Sonomura T, Mitsuzane K, et al. Self-expandable metallic stent therapy for superior vena cava syndrome: clinical observations. Radiology 1993;189:531-5.
11. Ahmann FR. A reassessment of the clinical implications of the superior vena caval syndrome. J Clin Oncol 1984;2:961-9.
12. Parish JM, Marschke RF Jr, Dines DE, Lee RE. Etiologic considerations in superior vena cava syndrome. Mayo Clin Proc 1981;56:407-13.
13. Chen JC, Bongard F, Klein SR. A comtemporary perspective on superior vena cava syndrome. Am J Surg 1990;160:207-11.
14. Rice TW, Rodriguez RM, Light RW. The superior vena cava syndrome: clinical characteristics and evolving etiology. Medicine (Baltimore) 2006;85:37-42.
15. Rice TW, Rodriguez RM, Barnette R, Light RW. Prevalence and characteristics of pleural effusions in superior vena cava syndrome. Respirology 2006;11:299-305.
16. Nicholson AA, Ettles DF, Arnold A, Greenstone M, Dyet JF. Treatment of malignant superior vena cava obstruction: metal stents or radiation therapy. J Vasc Interv Radiol 1997;8:781-8.
17. Detterbeck FC, Parsons AM. Thymic tumors. Ann Thorac Surg 2004;77:1860-9.
18. Urruticoechea A, Mesia R, Dominguez J, et al. Treatment of malignant superior vena cava syndrome by endovascular stent insertion: experience on 52 patients with lung cancer. Lung Cancer 2004;43:209-14.
19. Schwartz EE, Goodman LR, Haskin ME. Role of CT scanning in the superior vena cava syndrome. Am J Clin Oncol 1986;9:71-8.
20. Stanford W, Jolles H, Ell S, Chiu LC. Superior vena cava obstruction: a venographic classification. AJR Am J Roentgenol 1987;148:259-62.
21. Khimji T, Zeiss J. MRI versus CT and US in the evaluation of a patient presenting with superior vena cava syndrome: case report. Clin Imaging 1992;16:269-71.
22. Dosios T, Theakos N, Chatziantoniou C. Cervical mediastinoscopy and anterior mediastinoscopy in superior vena cava obstruction. Chest 2005;128:1551-6.
23. Porte H, Metois D, Finzi L, et al. Superior vena cava syndrome of malignant origin: which surgical procedure for which diagnosis? Eur J Cardiothorac Surg 2000;17:384-8.
24. Marcy PY, Magne N, Bentolila F, Drouillard J, Bruneton JN, Descamps B. Superior vena cava obstruction: is stenting necessary? Support Care Cancer 2001;9:103-7.
25. Greillier L, Barlesi F, Doddoli C, et al. Vascular stenting for palliation of superior vena cava obstruction in non-small-cell lung cancer patients: a future 'standard' procedure? Respiration 2004;71:178-83.
26. Tanigawa N, Sawada S, Mishima K, et al. Clinical outcome of stenting in superior vena cava syndrome associated with malignant tumors: comparison with conventional treatment. Acta Radiol 1998;39:669-74.
27. Sculier JP, Evans WK, Feld R, et al. Superior vena caval obstruction syndrome in small cell lung cancer. Cancer 1986;57:847-51.
28. Magnan PE, Thomas P, Guidicelli R, Fuentes P, Branchereau A. Surgical reconstruction of the superior vena cava. Cardiovasc Surg 1994;2:598-604.
29. Maddox AM, Valdivieso M, Lukeman J, et al. Superior vena cava obstruction in small cell bronchogenic carcinoma: clinical parameters and survival. Cancer 1983;52:2165-72.
30. Rowell NP, Gleeson FV. Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus: a systematic review. Clin Oncol (R Coll Radiol) 2002;14:338-51.
31. Anderson PR, Coia LR. Fractionation and outcomes with palliative radiation therapy. Semin Radiat Oncol 2000;10:191-9.
32. Spiro SG, Shah S, Harper PG, Tobias JS, Geddes DM, Souhami RL. Treatment of obstruction of the superior vena cava by combination chemotherapy with and without irradiation in small-cell carcinoma of the bronchus. Thorax 1983;38:501-5.
33. Pereira JR, Martins SJ, Ikari FK, Nikaedo SM, Gampel O. Neoadjuvant chemotherapy vs radiotherapy alone for superior vena cava syndrome (SVCS) due to non-small cell lung cancer (NSCLC): preliminary results of randomized phase II trial. Eur J Cancer 1999;35:Suppl 4:260. abstract.
34. Wurschmidt F, Bunemann H, Heilmann HP. Small cell lung cancer with and without superior vena cava syndrome: a multivariate analysis of prognostic factors in 408 cases. Int J Radiat Oncol Biol Phys 1995;33:77-82.
35. Chan RH, Dar AR, Yu E, et al. Superior vena cava obstruction in small-cell lung cancer. Int J Radiat Oncol Biol Phys 1997;38:513-20.
36. Fine DG, Shepherd RF, Welch TJ. Thrombolytic therapy for superior vena cava syndrome. Lancet 1989;1:1200-1.
37. Kee ST, Kinoshita L, Razavi MK, Nyman UR, Semba CP, Dake MD. Superior vena cava syndrome: treatment with catheter-directed thrombolysis and endovascular stent placement. Radiology 1998;206:187-93.
38. Courtheoux P, Alkofer B, Al Refai M, Gervais R, Le Rochais JP, Icard P. Stent placement in superior vena cava syndrome. Ann Thorac Surg 2003;75:158-61.
39. Uberoi R. Quality assurance guidelines for superior vena cava stenting in malignant disease. Cardiovasc Intervent Radiol 2006;29:319-22.
40. Smayra T, Otal P, Chabbert V, et al. Long-term results of endovascular stent placement in the superior vena caval venous system. Cardiovasc Intervent Radiol 2001;24:388-94.
41. Dhaliwal RS, Das D, Luthra S, Singh J, Mehta S, Singh H. Management of superior vena cava syndrome by internal jugular to femoral vein bypass. Ann Thorac Surg 2006;82:310-2.
42. Bacha EA, Chapelier AR, Macchiarini P, Fadel E, Dartevelle PG. Surgery for invasive mediastinal tumors. Ann Thorac Surg 1998;66:234-9.
43. Chen KN, Xu SF, Gu ZD, et al. Surgical treatment of complex malignant anterior mediastinal tumors invading the superior vena cava. World J Surg 2006;30:162-70.
44. Kalra M, Gloviczki P, Andrews JC, et al. Open surgical and endovascular treatment of superior vena cava syndrome caused by nonmalignant disease. J Vasc Surg 2003;38:215-23.
45. Inoue M, Minami M, Shiono H, et al. Efficient clinical application of percutaneous cardiopulmonary support for perioperative management of a huge anterior mediastinal tumor. J Thorac Cardiovasc Surg 2006;131:755-6.
46. Detterbeck FC, Jones DR, Kernstine KH, Naunheim KS. Lung cancer: special treatment issues. Chest 2003;123:Suppl 1:244S-258S.
47. Takeda S, Miyoshi S, Omori K, Okumura M, Matsuda H. Surgical rescue for life-threatening hypoxemia caused by a mediastinal tumor. Ann Thorac Surg 1999;68:2324-6.
48. Kvale PA, Simoff M, Prakash UBS. Lung cancer: palliative care. Chest 2003;123:Suppl 1:284S-311S.
49. NCCN Clinical Practice Guidelines in Oncology: non-small cell lung cancer. V. I.2007. National Comprehensive Cancer Network, 2007. (Accessed April 9, 2007, at http://www.nccn.org/professionals/physician_gls/PDF/nscl.pdf ).